Close Asset Management’s Dicerna Pharmaceuticals DRNA Stock Holding History
Bought
Maintained
Sold
Close Asset Management's DRNA Position: Q2 2022 in Review
Close Asset Management sold out of Dicerna Pharmaceuticals (DRNA) in Q2 2022, closing a stake of 2,000 shares — an estimated $76K sold.
Close Asset Management first reported a position in DRNA in Q3 2021 and held it in 3 quarters. The position peaked at $76K in Q1 2022. 0 funds tracked by Wall St. Rank hold DRNA as of Q2 2022.
- Close Asset Management reported no remaining Dicerna Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
- Close Asset Management sold 2,000 Dicerna Pharmaceuticals shares in Q2 2022, an estimated $76K.
- Close Asset Management first reported a position in Dicerna Pharmaceuticals in Q3 2021 and held it in 3 quarters.
- Close Asset Management's Dicerna Pharmaceuticals position peaked at $76K in Q1 2022.
- 0 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals as of Q2 2022.
Based on Close Asset Management's 13F filing for Q2 2022, filed 29 Jul 2022.